Logo image of ART.MI

DEODATO GALLERY SPA (ART.MI) Stock Fundamental Analysis

BIT:ART - Euronext Milan - IT0005528937 - Common Stock - Currency: EUR

0.286  -0.01 (-3.38%)

Fundamental Rating

2

Overall ART gets a fundamental rating of 2 out of 10. We evaluated ART against 52 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of ART is average, but there are quite some concerns on its profitability. ART is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ART has reported negative net income.
In the past year ART had a positive cash flow from operations.
ART.MI Yearly Net Income VS EBIT VS OCF VS FCFART.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.37%, ART is doing worse than 65.38% of the companies in the same industry.
ART has a Return On Equity (-0.97%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.37%
ROE -0.97%
ROIC N/A
ROA(3y)11.78%
ROA(5y)N/A
ROE(3y)40.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ART.MI Yearly ROA, ROE, ROICART.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 20 40 60

1.3 Margins

With a Gross Margin value of 21.42%, ART is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
ART does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ART.MI Yearly Profit, Operating, Gross MarginsART.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

ART does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ART remains at a similar level compared to 1 year ago.
ART has a better debt/assets ratio than last year.
ART.MI Yearly Shares OutstandingART.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
ART.MI Yearly Total Debt VS Total AssetsART.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

ART has an Altman-Z score of 2.24. This is not the best score and indicates that ART is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.24, ART is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
The Debt to FCF ratio of ART is 1.91, which is an excellent value as it means it would take ART, only 1.91 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.91, ART belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
ART has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.20, ART belongs to the best of the industry, outperforming 86.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.91
Altman-Z 2.24
ROIC/WACCN/A
WACC7.8%
ART.MI Yearly LT Debt VS Equity VS FCFART.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

ART has a Current Ratio of 1.74. This is a normal value and indicates that ART is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.74, ART belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
A Quick Ratio of 0.95 indicates that ART may have some problems paying its short term obligations.
ART has a Quick ratio (0.95) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 0.95
ART.MI Yearly Current Assets VS Current LiabilitesART.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

ART shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.20%.
Looking at the last year, ART shows a small growth in Revenue. The Revenue has grown by 6.62% in the last year.
EPS 1Y (TTM)-111.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.34%
Revenue 1Y (TTM)6.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.MI Yearly Revenue VS EstimatesART.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.MI Price Earnings VS Forward Price EarningsART.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

67.31% of the companies in the same industry are cheaper than ART, based on the Enterprise Value to EBITDA ratio.
71.15% of the companies in the same industry are more expensive than ART, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.79
EV/EBITDA 20.71
ART.MI Per share dataART.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ART!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEODATO GALLERY SPA

BIT:ART (4/22/2025, 7:00:00 PM)

0.286

-0.01 (-3.38%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.79%
Inst Owner ChangeN/A
Ins Owners83.3%
Ins Owner ChangeN/A
Market Cap8.96M
Analysts80
Price Target0.87 (204.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.88
P/FCF 11.79
P/OCF 6.9
P/B 1.9
P/tB 2.46
EV/EBITDA 20.71
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY8.49%
OCF(TTM)0.04
OCFY14.5%
SpS0.32
BVpS0.15
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.37%
ROE -0.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.42%
FCFM 7.49%
ROA(3y)11.78%
ROA(5y)N/A
ROE(3y)40.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)39.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.91
Debt/EBITDA 2.23
Cap/Depr 124.19%
Cap/Sales 5.31%
Interest Coverage N/A
Cash Conversion 314.07%
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 0.95
Altman-Z 2.24
F-Score3
WACC7.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.34%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-103.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-311.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1332.71%
OCF growth 3YN/A
OCF growth 5YN/A